(R)-(-)-4-Phenyl-2-Oxazolidinone CAS 90319-52-1 Ubunyulu ≥99.0% (HPLC) S-POZ Enantiomer ≤0.50% (HPLC) Chiral Compounds
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
(S)-(+)-4-Phenyl-2-Oxazolidinone CAS: 99395-88-7
(R)-(-)-4-Phenyl-2-Oxazolidinone CAS: 90319-52-1
IiCompounds zeChiral, uMgangatho oPhezulu, iMveliso yoRhwebo
Igama leMchiza | (R)-(-)-4-Phenyl-2-Oxazolidinone |
Izithethantonye | (R) -4-Phenyloxazolidin-2-enye;Ezetimibe Ukungcola |
Inombolo yeCAS | 90319-52-1 |
Inombolo yeCAT | RF-CC107 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C9H9NO2 |
Ubunzima beMolekyuli | 163.17 |
Ukuxinana | 1.195 g/cm3 |
Indawo yokunyibilika | 131.0 ukuba 133.0 ℃ |
Indawo yokubilisa | 407.0 kwi-760 mmHg |
Ukunyibilika | Inyibilika kwiChloroform, Ethyl Acetate kunye neMethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | ICrystalline eMhlophe okanye eNgakho-Mhlophe eSolid |
Ilahleko ekomisweni | ≤0.50% |
Ubunyulu / Indlela yokuHlalutya | ≥99.0% |
S-POZ Enantiomer | ≤0.50% |
Ukungacoceki komntu | ≤0.50% |
Ukungcola ngokupheleleyo | ≤1.0% |
Ukufuma (KF) | ≤0.50% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | IiCompounds zeChiral |
Iphakheji: Ibhotile, igubu leCardboard, 25kg/Drum, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi (R)-(-)-4-Phenyl-2-Oxazolidinone (CAS: 90319-52-1) kunye nomgangatho ophezulu, osetyenziswa ngokubanzi kwi-organic synthesis, synthesis. ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Ingredient (API) synthesis.
I-Shanghai Ruifu Chemical Co., Ltd. idlala indima ebalulekileyo kwi-chemistry ye-chiral, inkampani izinikele ekuveliseni i-chiral compounds.Iimveliso zethu zinconywa ngokubanzi ngabathengi.
(R)-(-)-4-Phenyl-2-oxazolidinone (CAS: 90319-52-1) i-compound luncedo kwi-organic synthesis, ingasetyenziselwa njenge-pharmaceutical intermediates, ngokukodwa kwi-asymmetric chiral synthesis.Liphakathi kwi-Ezetimibe.